Expand MRNA Menu
MRNA MENU

MRNA Stock Summary and Trading Ideas (Moderna | NASDAQ:MRNA)

Charts for Today's Stock Price and Implied Volatility in Moderna

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for MRNA by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Moderna (MRNA) Frequently Asked Questions

What does Moderna do?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

What symbol and exchange does Moderna stock trade?

Moderna trades on the NASDAQ stock market under the symbol MRNA.

What is Moderna stock price doing today?

As of May 13, 2024, MRNA stock price climbed to $122.52 with 1,011,310 million shares trading.

What is Moderna's Beta?

MRNA has a beta of 1.69, meaning it tends to be more sensitive to market movements. MRNA has a correlation of 0.17 to the broad based SPY ETF.

How much is Moderna worth?

MRNA has a market cap of $46.91 billion. This is considered a Large Cap stock.

How much money does Moderna make?

Last quarter Moderna reported $167 million in Revenue and -$3.07 earnings per share. This beat revenue expectation by $76 million and exceeded earnings estimates by $.28.

What is the highest and lowest price Moderna traded in the last 3 year period?

In the last 3 years, MRNA stock traded as high as $497.49 and as low as $62.55.

What are the top ETFs holding Moderna?

The top ETF exchange traded funds that MRNA belongs to (by Net Assets): VTI, VOO, QQQ, VO, SPY.

Is Moderna (MRNA) a good investment?

MRNA stock has underperformed the market in the last year with a return of -6.4%, while SPY returned +27.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MRNA shares. However, MRNA has outperformed the market in the last 3 month and 2 week periods, returning +40.2% and +13.5%, while SPY returned +4.3% and +2.5%, respectively. This indicates MRNA has been having a stronger performance recently.

What is the support and resistance for Moderna (MRNA) stock price?

MRNA support price is $114.18 and resistance is $120.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNA stock will trade within this expected range on the day.